We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
EYE Stock: Valuation, Price Target, and Key Upside Drivers
Read MoreHide Full Article
Key Takeaways
EYE trades at 0.6X forward sales, with a $17 price target based on that valuation framework.
National Vision posted 4.5% adjusted comp sales growth in Q1 and guides 3%-6% growth for 2026.
EYE improved liquidity and margins, but digital disruption and vendor concentration remain risks.
National Vision Holdings, Inc. (EYE - Free Report) has started 2026 under pressure, with shares down 37.7% year to date. That pullback is shifting the investor conversation away from big-picture narratives and toward what the valuation is now assuming.
Image Source: Zacks Investment Research
At today’s level, the setup is largely about whether operations can stabilize enough to support a low sales multiple. EYE is trading around 0.6X forward 12-month sales, putting the spotlight on execution over the next several quarters.
Image Source: Zacks Investment Research
EYE Shares Fell, but Sales Multiple Looks Compressed
At roughly 0.6X forward 12-month sales, EYE sits well below the comparison multiples cited for the Zacks sub-industry (2.2X), the Zacks sector (7.7X) and the S&P 500 (5.3X). The discount signals skepticism that recent operational improvements can persist.
The stock’s own range shows how far expectations have reset. Over the past five years, EYE has traded between 0.4X and 2.4X forward sales, with a median of 0.9X. With shares closer to the lower end after the drawdown, upside depends on reducing execution noise and staying inside guidance.
National Vision Price Target Anchors the Base Case
The 6–12-month price target is $17. Rather than assuming a premium valuation, the target is built on a forward sales multiple framework.
Specifically, the $17 target reflects 0.6X forward 12-month sales. In other words, the base case is not assuming an aggressive multiple expansion. It is effectively anchored to where the stock already trades, which puts more weight on whether fundamentals can reduce uncertainty and support that valuation over the next several quarters.
EYE Short-Term Rating Signals Caution
The near-term model signal is cautious. EYE carries a Zacks Rank #4 (Sell), a one-to three-month signal driven by trends in earnings estimate revisions. That rating argues for caution on timing, even if longer-term initiatives are progressing. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Style Scores are more constructive. The VGM score is A, with Value at B and Growth at A, while Momentum is C. In the same industry snapshot, Walmart Inc. (WMT - Free Report) and Costco Wholesale Corporation (COST - Free Report) show up as large, established peers, a reminder that competitive intensity remains high even when EYE’s valuation looks inexpensive.
National Vision: What Must Go Right from Here
Comparable sales must hold in the guided band. In the first quarter of 2026, adjusted comparable store sales rose 4.5%, helped by higher average ticket and managed care momentum, partly offset by softer self-pay traffic. For fiscal 2026, adjusted comparable store sales growth is guided to 3% to 6%.
The mix shift and cost discipline also have to stay intact. Management highlighted momentum in managed care, progressive and outside-prescription customers, alongside trade-up initiatives tied to a more premium frame and lens mix and broader smart-glasses availability. Profitability improved in the first quarter, with operating margin reaching 8.3%, up about 320 basis points year over year.
EYE Omnichannel Fixes Are a Near-Term Swing Factor
Digital performance is a swing factor because conversion and traffic can move sharply during platform changes. The replatforming of americasbest.com at the start of the second quarter disrupted traffic as search and social signals reset. Management cited sequential improvement through the quarter and maintained full-year guidance, but the incident raises execution risk.
That risk matters because EYE competes with national optical retailers and online-focused players on price, convenience, assortment and service. If digital conversion lags, short-term demand can leak to competitors even if the long-term goal is a stronger omnichannel foundation.
National Vision Balance Sheet Progress Helps, Leverage Matters
Liquidity improved in the first quarter. Cash rose to $67.9 million from $38.7 million at the end of 2025, and operating cash flow was $61.7 million. Total debt was $241.8 million, and the company reported no borrowings under its $300 million revolver, excluding letters of credit.
Leverage still matters because reinvestment needs continue and financing costs can swing results. Management’s 2026 outlook assumes interest expense of $14 million to $16 million, keeping sensitivity to rates and operating variance on the checklist.
EYE Risk Checklist Before Taking Action
Before acting, investors should pressure-test a few specific risks. Vendor concentration stands out. In fiscal 2025, approximately 86% of lens expenditures came from one vendor, and nearly 96% of contact lens expenditures were with three vendors. A disruption could affect pricing, product availability and service levels.
Next, weigh competition and cost volatility. The company faces competitive pressure across channels, while expenses are sensitive to mix, input inflation and potential tariff-related volatility. Higher inventory to support premium rollouts and store segmentation increases allocation demands and markdown risk if demand shifts, and continued self-pay softness remains an additional watch item.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
EYE Stock: Valuation, Price Target, and Key Upside Drivers
Key Takeaways
National Vision Holdings, Inc. (EYE - Free Report) has started 2026 under pressure, with shares down 37.7% year to date. That pullback is shifting the investor conversation away from big-picture narratives and toward what the valuation is now assuming.
Image Source: Zacks Investment Research
At today’s level, the setup is largely about whether operations can stabilize enough to support a low sales multiple. EYE is trading around 0.6X forward 12-month sales, putting the spotlight on execution over the next several quarters.
Image Source: Zacks Investment Research
EYE Shares Fell, but Sales Multiple Looks Compressed
At roughly 0.6X forward 12-month sales, EYE sits well below the comparison multiples cited for the Zacks sub-industry (2.2X), the Zacks sector (7.7X) and the S&P 500 (5.3X). The discount signals skepticism that recent operational improvements can persist.
The stock’s own range shows how far expectations have reset. Over the past five years, EYE has traded between 0.4X and 2.4X forward sales, with a median of 0.9X. With shares closer to the lower end after the drawdown, upside depends on reducing execution noise and staying inside guidance.
National Vision Price Target Anchors the Base Case
The 6–12-month price target is $17. Rather than assuming a premium valuation, the target is built on a forward sales multiple framework.
Specifically, the $17 target reflects 0.6X forward 12-month sales. In other words, the base case is not assuming an aggressive multiple expansion. It is effectively anchored to where the stock already trades, which puts more weight on whether fundamentals can reduce uncertainty and support that valuation over the next several quarters.
EYE Short-Term Rating Signals Caution
The near-term model signal is cautious. EYE carries a Zacks Rank #4 (Sell), a one-to three-month signal driven by trends in earnings estimate revisions. That rating argues for caution on timing, even if longer-term initiatives are progressing. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Style Scores are more constructive. The VGM score is A, with Value at B and Growth at A, while Momentum is C. In the same industry snapshot, Walmart Inc. (WMT - Free Report) and Costco Wholesale Corporation (COST - Free Report) show up as large, established peers, a reminder that competitive intensity remains high even when EYE’s valuation looks inexpensive.
National Vision: What Must Go Right from Here
Comparable sales must hold in the guided band. In the first quarter of 2026, adjusted comparable store sales rose 4.5%, helped by higher average ticket and managed care momentum, partly offset by softer self-pay traffic. For fiscal 2026, adjusted comparable store sales growth is guided to 3% to 6%.
The mix shift and cost discipline also have to stay intact. Management highlighted momentum in managed care, progressive and outside-prescription customers, alongside trade-up initiatives tied to a more premium frame and lens mix and broader smart-glasses availability. Profitability improved in the first quarter, with operating margin reaching 8.3%, up about 320 basis points year over year.
EYE Omnichannel Fixes Are a Near-Term Swing Factor
Digital performance is a swing factor because conversion and traffic can move sharply during platform changes. The replatforming of americasbest.com at the start of the second quarter disrupted traffic as search and social signals reset. Management cited sequential improvement through the quarter and maintained full-year guidance, but the incident raises execution risk.
That risk matters because EYE competes with national optical retailers and online-focused players on price, convenience, assortment and service. If digital conversion lags, short-term demand can leak to competitors even if the long-term goal is a stronger omnichannel foundation.
National Vision Balance Sheet Progress Helps, Leverage Matters
Liquidity improved in the first quarter. Cash rose to $67.9 million from $38.7 million at the end of 2025, and operating cash flow was $61.7 million. Total debt was $241.8 million, and the company reported no borrowings under its $300 million revolver, excluding letters of credit.
Leverage still matters because reinvestment needs continue and financing costs can swing results. Management’s 2026 outlook assumes interest expense of $14 million to $16 million, keeping sensitivity to rates and operating variance on the checklist.
EYE Risk Checklist Before Taking Action
Before acting, investors should pressure-test a few specific risks. Vendor concentration stands out. In fiscal 2025, approximately 86% of lens expenditures came from one vendor, and nearly 96% of contact lens expenditures were with three vendors. A disruption could affect pricing, product availability and service levels.
Next, weigh competition and cost volatility. The company faces competitive pressure across channels, while expenses are sensitive to mix, input inflation and potential tariff-related volatility. Higher inventory to support premium rollouts and store segmentation increases allocation demands and markdown risk if demand shifts, and continued self-pay softness remains an additional watch item.